Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines

Core Points - Bavarian Nordic announced a donation of 110,000 doses of mpox vaccines to Africa CDC to support the ongoing mpox outbreak in Africa [1][2] - The donation is aimed at increasing vaccine availability in Uganda, which has reported the second-highest number of mpox cases in Africa in 2025 [2] - With this latest donation, Bavarian Nordic has committed a total of 165,000 doses of the MVA-BN vaccine to Africa [3] Company Overview - Bavarian Nordic is a global vaccine company focused on improving health and saving lives through innovative vaccines [5] - The company is a preferred supplier of mpox and smallpox vaccines to governments, enhancing public health preparedness [5] - MVA-BN, the vaccine donated, is the only non-replicating mpox vaccine approved in several countries, including the U.S. and EU [4]